Nasal Drug Delivery Technology Market Report
RA01954
Nasal Drug Delivery Technology Market , by Application (Allergic And Non-allergic Rhinitis, Nose Congestion, Vaccination, Other Therapeutic Applications), End Use (Home Care Settings, Hospitals), System (Multi-dose Systems, Bi-dose Systems, Unit-dose Systems), Dosage Form (Sprays, Drops & Liquids, Powders, Gels): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global nasal drug delivery technology market
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Nasal Drug Delivery Technology Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Nasal Drug Delivery Technology Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Nasal Drug Delivery Technology Market , By Device Type
5.1. Overview
5.2 Allergic And Non-allergic Rhinitis
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Nose Congestion
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Vaccination
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Other Therapeutic Applications
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Research Dive Exclusive Insights
5.6.1 Market attractiveness
5.6.2 Competition heatmap
-
6. Nasal Drug Delivery Technology Market , By Type
6.1. Overview
6.2 Home Care Settings
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Hospitals
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Research Dive Exclusive Insights
6.4.1 Market attractiveness
6.4.2 Competition heatmap
-
7. Nasal Drug Delivery Technology Market , By Disease Type
7.1. Overview
7.2 Multi-dose Systems
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Bi-dose Systems
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Unit-dose Systems
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Research Dive Exclusive Insights
7.5.1 Market attractiveness
7.5.2 Competition heatmap
-
8. Nasal Drug Delivery Technology Market , By Delivery Mode
8.1. Overview
8.2 Sprays
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Drops & Liquids
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Powders
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Gels
8.5.1 Definition, key trends, growth factors, and opportunities
8.5.2 Market size analysis, by region, 2020-2027
8.5.3 Market share analysis, by country, 2020-2027
8.6 Research Dive Exclusive Insights
8.6.1 Market attractiveness
8.6.2 Competition heatmap
9. Nasal Drug Delivery Technology Market , By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By Device Type, 2020-2027
9.1.1.2 Market size analysis, By Type, 2020-2027
9.1.1.3 Market size analysis, By Disease Type, 2020-2027
9.1.1.4 Market size analysis, By Delivery Mode, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By Device Type, 2020-2027
9.1.2.2 Market size analysis, By Type, 2020-2027
9.1.2.3 Market size analysis, By Disease Type, 2020-2027
9.1.2.4 Market size analysis, By Delivery Mode, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By Device Type, 2020-2027
9.1.3.2 Market size analysis, By Type, 2020-2027
9.1.3.3 Market size analysis, By Disease Type, 2020-2027
9.1.3.4 Market size analysis, By Delivery Mode, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By Device Type, 2020-2027
9.2.1.2 Market size analysis, By Type, 2020-2027
9.2.1.3 Market size analysis, By Disease Type, 2020-2027
9.2.1.4 Market size analysis, By Delivery Mode, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By Device Type, 2020-2027
9.2.2.2 Market size analysis, By Type, 2020-2027
9.2.2.3 Market size analysis, By Disease Type, 2020-2027
9.2.2.4 Market size analysis, By Delivery Mode, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By Device Type, 2020-2027
9.2.3.2 Market size analysis, By Type, 2020-2027
9.2.3.3 Market size analysis, By Disease Type, 2020-2027
9.2.3.4 Market size analysis, By Delivery Mode, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By Device Type, 2020-2027
9.2.4.2 Market size analysis, By Type, 2020-2027
9.2.4.3 Market size analysis, By Disease Type, 2020-2027
9.2.4.4 Market size analysis, By Delivery Mode, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By Device Type, 2020-2027
9.2.5.2 Market size analysis, By Type, 2020-2027
9.2.5.3 Market size analysis, By Disease Type, 2020-2027
9.2.5.4 Market size analysis, By Delivery Mode, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By Device Type, 2020-2027
9.2.6.2 Market size analysis, By Type, 2020-2027
9.2.6.3 Market size analysis, By Disease Type, 2020-2027
9.2.6.4 Market size analysis, By Delivery Mode, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By Device Type, 2020-2027
9.3.1.2 Market size analysis, By Type, 2020-2027
9.3.1.3 Market size analysis, By Disease Type, 2020-2027
9.3.1.4 Market size analysis, By Delivery Mode, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By Device Type, 2020-2027
9.3.2.2 Market size analysis, By Type, 2020-2027
9.3.2.3 Market size analysis, By Disease Type, 2020-2027
9.3.2.4 Market size analysis, By Delivery Mode, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By Device Type, 2020-2027
9.3.3.2 Market size analysis, By Type, 2020-2027
9.3.3.3 Market size analysis, By Disease Type, 2020-2027
9.3.3.4 Market size analysis, By Delivery Mode, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By Device Type, 2020-2027
9.3.4.2 Market size analysis, By Type, 2020-2027
9.3.4.3 Market size analysis, By Disease Type, 2020-2027
9.3.4.4 Market size analysis, By Delivery Mode, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By Device Type, 2020-2027
9.3.5.2 Market size analysis, By Type, 2020-2027
9.3.5.3 Market size analysis, By Disease Type, 2020-2027
9.3.5.4 Market size analysis, By Delivery Mode, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By Device Type, 2020-2027
9.3.6.2 Market size analysis, By Type, 2020-2027
9.3.6.3 Market size analysis, By Disease Type, 2020-2027
9.3.6.4 Market size analysis, By Delivery Mode, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By Device Type, 2020-2027
9.4.1.2 Market size analysis, By Type, 2020-2027
9.4.1.3 Market size analysis, By Disease Type, 2020-2027
9.4.1.4 Market size analysis, By Delivery Mode, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By Device Type, 2020-2027
9.4.2.2 Market size analysis, By Type, 2020-2027
9.4.2.3 Market size analysis, By Disease Type, 2020-2027
9.4.2.4 Market size analysis, By Delivery Mode, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By Device Type, 2020-2027
9.4.3.2 Market size analysis, By Type, 2020-2027
9.4.3.3 Market size analysis, By Disease Type, 2020-2027
9.4.3.4 Market size analysis, By Delivery Mode, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By Device Type, 2020-2027
9.4.4.2 Market size analysis, By Type, 2020-2027
9.4.4.3 Market size analysis, By Disease Type, 2020-2027
9.4.4.4 Market size analysis, By Delivery Mode, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By Device Type, 2020-2027
9.4.5.2 Market size analysis, By Type, 2020-2027
9.4.5.3 Market size analysis, By Disease Type, 2020-2027
9.4.5.4 Market size analysis, By Delivery Mode, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Merck & Co., Inc.
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 Novartis AG.
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 Johnson& Johnson Services, Inc. .
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 Pfizer, Inc. .
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 AstraZeneca Plc.
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Aptar Group .
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 GlaxoSmithKline plc
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Procter & Gamble
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Janssen Global Services, LLC
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 OptiNose US Inc.,
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
